HKD 3.05
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -285.99 Million CNY | -72.64% |
2022 | -165.65 Million CNY | 71.18% |
2021 | -574.71 Million CNY | -506.14% |
2020 | 141.5 Million CNY | 10.88% |
2019 | 127.61 Million CNY | 151.19% |
2018 | -249.29 Million HKD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -140.48 Million CNY | 50.88% |
2024 Q2 | -140.48 Million CNY | 20.2% |
2023 Q3 | 129.6 Million CNY | 130.58% |
2023 FY | -285.99 Million CNY | -72.64% |
2023 Q2 | -423.76 Million CNY | -40.52% |
2023 Q1 | -301.57 Million CNY | -82.05% |
2023 Q4 | -285.99 Million CNY | -320.67% |
2022 Q2 | -695.67 Million HKD | 0.0% |
2022 Q3 | -38.28 Million CNY | 94.5% |
2022 Q4 | -165.65 Million CNY | -332.75% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Life Healthcare Group Limited | 5.23 Million HKD | 5564.133% |
China Biotech Services Holdings Limited | -106.5 Million HKD | -168.538% |